Prevent the development of chemoresistance.
Decrease the effective dose of chemotherapy, reducing negative side effects.
Resensitize chemoresistant tumors that have already become resistant to chemotherapy.
The Details: How It Works
Through utilizing a common biomarker found in multiple types of chemoresistant cancers, Chemosense has developed a novel therapy that specifically targets and blocks receptors that promote and maintain chemoresistance. Through repurposing drugs already used in other areas of the clinic to target these receptors, this new therapy cuts to the core of chemoresistance, sensitizing tumors to the tumor shrinking effects of chemotherapy.